期刊文献+

人附睾分泌蛋白4在卵巢成熟畸胎瘤诊断中的临床应用价值 被引量:2

Clinical Values of Serum Human Epididymis Secretory Protein 4 in the Diagnosis of Mature Ovarian Teratoma
下载PDF
导出
摘要 目的:探讨人附睾分泌蛋白4(HE4)在卵巢成熟畸胎瘤诊断中的临床应用价值。方法:选取88例卵巢成熟畸胎瘤患者(实验组)、80例健康女性(对照组),术前、术后采用酶联免疫法(ELISA)检测血清HE4水平;电化学发光免疫分析法检测血清CA199水平。通过制作受试者工作特征曲线(ROC),以曲线下面积(AUC)反映诊断的准确性,比较HE4及CA199对卵巢成熟畸胎瘤诊断的敏感度、特异度和阳性率。结果:实验组术前血清HE4和CA199水平分别为94.56pmol/L和54.72kU/L,对照组为29.13pmol/L和15.47kU/L,实验组均明显高于对照组,分别比较,差异有统计学意义(P<0.01,P<0.05)。实验组术后血清HE4和CA199水平分别为29.21pmol/L和18.23kU/L,术后血清HE4和CA199水平下降幅度比较,差异有统计学意义(P<0.01)。实验组检测HE4阳性率54.5%,CA199阳性率26.1%(P<0.05)。血清HE4和CA199单项检测的AUC分别为0.921和0.628;特异度为95%时的敏感度分别为64.3%和21.6%;特异度分别为96.2%和88.9%。结论:HE4在卵巢成熟畸胎瘤诊断中有意义,其检测阳性率高于CA199,诊断准确性、敏感度和特异度均优于CA199。 Objective:To explore the clinical values of human epididymis secretory protein 4 in diagnosis of mature ovarian teratoma. Methods :88 patients with mature ovarian teratoma and 80 cases of healthy con- trol were enrolled at the first affiliated hospital of Harbin medical university between January 2011 and April 2012,whose serum HE4 and CA199 levels were respectively detected by ELISA and ECLIA before and after operation. The sensitivity, specificity, and positive rate of HE4 and CA199 in the diagnosis of mature ovarian teratoma were compared through ROC-AUC. Results:The serum HE4 and CA I~ levels of patients with ma- ture ovarian teratoma before operation were respectively 94. 56 pmol/L and 54.72 kU/L,which were signifi- cantly higher than the control group whose results were 29, 13 pmoVL and 15.47 kU/L( P 〈 0.01 ; P 〈 0.05). The serum levels of two indexes in mature ovariat~ teratoma patients after operation were 29.21 pmol/L and 18, 23 kU/L,which were significantly lower than the levels before operation( P 〈 0, 01 ). With the control group as the reference,the single detection AUC of HE4 and CA^99 in patients with mature ovarian teratoma were 0. 921 and 0. 628 respectively. Tumor marker sensitivity were 64. 3% and 21.6% respectively at the specificity was 95%, meanwhile the specificity of both were 96.2% and 88. 9% respectively. The posi- tive rate of HE4(54.5% )were significantly higher than CA199 (26. 1% ) ( P 〈 0.05). Conclusions:The HE4 has potential value in the diagnosis of ovarian teratoma,whose sensitivity,specificity and positive rate are bet- ter than CA199.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2013年第3期211-214,共4页 Journal of Practical Obstetrics and Gynecology
关键词 人附睾分泌蛋白 癌抗原199 卵巢成熟畸胎瘤 Human epididymis secretory protein 4 Cancer antigen199 Mature ovarian teratoma
  • 相关文献

参考文献11

  • 1Tsai CK, Huang TW, Li CC, et al. Cystic seminoma with elevated val- ue of carbohydrate antigen 19-9 in tumor fluid mimicking cystic tera- toma[ J]. Ann Thorac Surg,2009,88 ( 5 ) : 1693-1695.
  • 2陈晨,李俊东,黄鹤,冯艳玲,王銮虹,陈亮.肿瘤标志物检测对卵巢成熟、未成熟畸胎瘤的诊断价值[J].癌症,2008,27(1):92-95. 被引量:45
  • 3Ustunyurt E, Gungor T, Iskender C, et al. Tumor markers in mature cystic teratomas of the ovary [ J ]. Arch Gynecol Obstet, 2009,279 (2) :145 -147.
  • 4Moore RG, Brown AK, Miller MC, et al. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus [ J ]. Gyneeol Oneol, 2008,110 (2) : 196 - 201.
  • 5Emin U,Tayfnn G, Cantekin I, et al. Tumor markers in mature cystic teratomas of the ovary [ J ]. Arch Gynecol Obstet, 2009,279 ( 2 ) : 145 - 147.
  • 6Coskun A,Kiran G, Ozdemir O. CA 199 can be a useful tumor marker in ovarian dermoid cysts[J]. Clin Exp Obstet Gynecol,2008,35(2) : 137 - 139.
  • 7Jacob F, Meier M, Caduff R, et al. No benefit from combining HFA and CA125 as ovarian tumor markers in a clinical setting[J]. Gynecol Oncol,2011,121 (3) :487 - 491.
  • 8Moore RG,Brown AK, Miller MC,et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass [ J ]. Gynecologic Oncology, 2008, 108 ( 2 ) : 402 - 408.
  • 9Paek J,Lee SH,Yim GW,et al. Prognostic significance of human epi- didymis protein :4 in epithelial ovarian cancer[ J ]. Eur J Obstet Gyne- col,2011,158 (2) :338 -342.
  • 10Park Y, Lee JH, Hong D J, et al. Diagnostic performances of HE4 and CA 125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases [ J ]. Clinical Biochemistry,2011,44( 10 - 11 ) :884 - 888.

二级参考文献10

  • 1龚晓明,冷金花,郎景和,黄荣丽,刘珠凤,孙大为,朱兰.卵巢成熟畸胎瘤695例临床分析[J].中国医学科学院学报,2004,26(6):692-695. 被引量:51
  • 2申桂华,姜展红,陈德新.血清肿瘤标记物测定在卵巢成熟畸胎瘤及其恶变者的临床应用[J].中国癌症杂志,2006,16(5):370-373. 被引量:8
  • 3Calder C T, Light A M, Rollason T P. Immature ovarian teratoma with mature peritoneal metastatic deposits showing glial, epithelial and endometioid differentiation: a case report and review of the literature [J]. Gynecol Pathol, 1994,13(3): 279-282.
  • 4Gallion H, van Nagell J R Jr, Donaldson E S, et al. Immature teratoma of the ovary [J]. Am J Obstet Gynecol, 1983,146(4) : 361-365.
  • 5Dede M, Gungor S, Yenen M C, et al. CA19-9 may have clinical significance in mature cystic teratomas of the ovary [J]. Gynecol Cancer, 2006, 16( 1 ) : 189-193.
  • 6Kikkawa F, Nawa A, Tamakoshi K, et al. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary [J ]. Cancer, 1998,82 ( 11 ) : 2249-2255.
  • 7Malogolowkin M H, Ortega J A, Kralio M, et al. Immature teratomas: identification of patients at risk for malignant recurrence [J]. Natl Cancer Inst, 1989,81 ( 11 ) : 870-874.
  • 8Kawata M, Sekiya S, Hatakeyama R, et al. Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma [J]. Gynecol Oncol, 1989,32(2):191-197.
  • 9Kawai M, Kano T, Kikkawa F, et al. Seven tumor markers in benign and malignant germ cell tumors of the ovary. [J]. Gynecol Oncol, 1992,45 ( 3 ) : 248-253.
  • 10李福玉,韦福康,胡颖川,白令.小儿卵巢畸胎瘤伴腹膜神经胶质增多症3例[J].中国肿瘤临床,2001,28(4):302-302. 被引量:11

共引文献44

同被引文献40

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部